In vitro Activity of Novel Cannabinoids Derived from Tetrahydrocan-nabinolic Acid on Various Human Tumor Cell Lines  

作　　者：Alexander Aizikovich 

机构地区：[1]CEO AL&AM Pharmachem Ltd,Rehovot,7630505,Israel

出　　处：《Journal of Oncology Research》2021年第2期55-59,共5页肿瘤学研究杂志（英文）

基　　金：This work was funded from the AL&AM Pharmachem Ltd.company's own funds.(Grant ALAM2019-001).

摘　　要：The in vitro study of tetracannabinolic acid(THCA)derivatives ALAM027 and ALAM108 was carried out on the following human tumor cells:T47D(breast,ductal carcinoma),PC-3(prostate,adenocarcinoma),HT 29(colorectal carcinoma),Caco-2(colon,adenocarcinoma),A549(lung,carcinoma),U87MG(human glioblastoma)and U266B1(multiple myeloma).The in vitro effects of THCA derivatives ALAM027 and ALAM108 on cell growth inhibition and IC50 values were measured using the CellTiter Glo assay.The ALAM027 compound showed good growth inhibition in all cell lines tested with the exception of U87MG cells.The ALAM108 compound also suppressed the growth of U87 MG cells but had little effect on T47D tumor cells.In vitro studies of THCA derivatives ALAM027 and ALAM108 showed antitumor activity in all cell lines tested.The difference in the activity of these compounds in relation to the T47D and U87MG tumor cells may be indicative of different functional mechanisms.

关 键 词：THCA CANNABINOIDS T47D PC-3 HT-29 CACO-2 A549 U87MG U266B 

分 类 号：R73[医药卫生—肿瘤]